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Wuppertal and Munich, GermanyObjectives This study sought to evaluate the impact of anatomic and procedural variables on the
outcome of the unprotected left main coronary artery (uLMCA) itself after drug-eluting stent (DES)
implantation.
Background There is a controversial debate regarding when and how to perform percutaneous
coronary intervention (PCI) for an uLMCA stenosis.
Methods This analysis is based on a randomized study of 607 patients undergoing PCI for uLMCA,
randomized 1:1 to receive paclitaxel- or sirolimus-eluting stents. We evaluated the impact of the
SYNTAX score, uLMCA anatomy, and stenting technique on in-stent restenosis (ISR), target lesion
revascularization (TLR), and the 3-year outcomes.
Results The 3-year cardiac mortality rate was 5.8%; 235 (39%) patients had a true bifurcation lesion
(TBL), and the median SYNTAX score was 27. TBL was associated with a higher need for multiple stents
(72% vs. 37%, p < 0.001). TBL was a signiﬁcant predictor of ISR (23% vs. 14%, p ¼ 0.008) and for TLR
(18% vs. 9%, p < 0.001). The need for multiple stents was a predictor of ISR (22% vs. 13%, p ¼ 0.005)
and for TLR (16% vs. 9%, p ¼ 0.005). Culotte stenting showed better results compared with T-stenting
for ISR (21% vs. 56%, p ¼ 0.02) and for TLR (15% vs. 56%, p < 0.001). We observed a signiﬁcant
association between uLMCA-TLR and SYNTAX scores (9.2% for scores 22, 14.9% for scores 23 to
32, and 13.0% for scores 33, p ¼ 0.008).
Conclusions PCI of uLMCA lesions with DES is safe and effective out to 3 years. TBL and multiple
stents were independent predictors for ISR. In the multivariate analysis, independent predictors for
TLR were TBL, age, and EuroSCORE (European System for Cardiac Operative Risk Evaluation). (Drug-
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30Signiﬁcant left main disease is observed with increasing
incidence, given the progressively older patients with higher
prevalence of cardiovascular risk factors (1). Left main
disease has a signiﬁcant impact on the symptomatic and
prognostic outcome, with a controversial debate regarding
the optimal treatment (1–3). Early studies using bare-metal
stents have shown high restenosis rates, especially in the
presence of left main bifurcation lesions, declaring elective
left main percutaneous interventions to be almost a taboo or
a palliative approach (1,2). Large randomized trials showed
a reduction of restenosis rates in non-left main lesions by
60% to 80% using drug-eluting stents (DES) compared with
bare-metal stents, reaching low single-digit rates with
different DES (2–9).See page 37
Abbreviations
and Acronyms
CABG = coronary artery
bypass graft surgery
DES = drug-eluting stent(s)
ISR = in-stent restenosis
LCX = left circumﬂex
coronary artery
LMCA = left main coronary
artery
MACE = major adverse
cardiac event(s)
MI = myocardial infarction
PCI = percutaneous coronary
intervention
TBL = true bifurcation lesion
TLR = target lesion
revascularization
uLMCA = unprotected left
main coronary arteryIn the last few years, different
randomized and nonrandomized
studies have addressed the per-
cutaneous coronary intervention
(PCI) of the unprotected left
main coronary artery (uLMCA)
with DES and compared it with
aorto-coronary artery bypass graft
surgery (CABG) (3,10–12). The
largest trial to date, the SYNTAX
(Synergy Between PCI With
TAXUS and Cardiac Surgery)
trial, randomized 1,800 patients
with 3-vessel disease and/or left
main lesions into 2 equally large
groups, comparing PCI using the
ﬁrst-generation Taxus DES with
CABG (3). In the overall pop-
ulation, major adverse cardiac or
cerebrovascular events at 1 year
were higher in the PCI groupbecause of an increased rate of repeat revascularization; the
hard safety endpoint, including death and myocardial
infarction (MI), was similar between the 2 groups, whereas
stroke occurred signiﬁcantly more often after CABG (3).
Interestingly, within the subgroup of the 705 patients with
left main stenosis, the primary endpoint major adverse cardiac
or cerebrovascular events was not different between PCI and
CABG (p ¼ 0.44), with a better outcome after PCI in the
left main subgroup compared with the other patients (13).
Despite these results, the worldwide proportion of patients
treated with PCI compared with CABG is still higher for
patients with 3-vessel disease compared with patients with
left main disease, who are often still sent to CABG (14).
This might be related to the frequent involvement of the
challenging uLMCA bifurcation and concerns of restenosis
requiring complex re-interventions, whereas restenosis inthe rest of the coronary tree is felt to be treated safely
nowadays. But there is no systematic analysis on the basis
of an adequate number of left main lesions treated with
DES implantation regarding the impact of coronary
anatomy, stenting technique, full DES coverage, need for
ﬁnal kissing balloon dilation, and overall coronary disease
burden regarding the outcome of the important left main
site. To our knowledge, this is the ﬁrst analysis to
systematically address these issues.
Methods
Patient population and analyzed variables. This analysis is
based on the previously published randomized ISAR-LEFT
MAIN (Drug-Eluting-Stents for Unprotected Left Main
StemDisease) study including 607 symptomatic patients with
uLMCA disease undergoing PCI (10); 302 patients were
assigned to receive a paclitaxel-eluting stent (Taxus, Boston
Scientiﬁc, Natick,Massachusetts) and 305 assigned to receive
a sirolimus-eluting stent (Cypher, Cordis, East Bridgewater,
New Jersey) (10). The primary trial focused on the comparison
of the 2 different stent platforms and showed no signiﬁcant
difference in the outcome between paclitaxel-eluting stents
and sirolimus-eluting stents, with an overall low MACE
(major adverse cardiac events) rate, comparable to the
SYNTAX trial (3,10). Given the similar outcome of the
2 stent platforms, this current analysis evaluated the prog-
nostic impact of the overall coronary anatomy (reﬂected by the
SYNTAX score), the left main anatomy, and the stenting
technique on the angiographic restenosis rate (in-stent
restenosis [ISR]) and target lesion revascularization (TLR) for
the left main itself, independent of the DES used.
The methods of the randomized ISAR-Left Main trial
have been published in detail (10). Written informed consent
for participation in this trial has been obtained from all
subjects (or their guardians). The study was conducted in
accordance with the provisions of the Declaration of Helsinki
and with the International Conference on Harmonisation’s
Good Clinical Practices, and protocol approval was obtained
from the medical ethics committee for both participating
centers, the Deutsches Herzzentrum and Medizinische Kli-
nik I, Klinikum Rechts der Isar, Munich, Germany (10).
We assessed the Parsonnet score and EuroSCORE
(European System for Cardiac Operative Risk Evaluation)
to evaluate possible differences between the subgroups
(15–17). Baseline, procedural, and follow-up coronary
angiograms were digitally recorded and assessed off-line in
the quantitative angiographic core laboratory (ISAR Center,
Munich) with an automated edge-detection system (CMS
version 7.1, Medis Medical Imaging Systems, Leiden, the
Netherlands) by 2 independent experienced operators
unaware of the treatment allocation and clinical character-
istics. Quantitative analysis was performed on the left main
area, which was considered the anatomic coronary region
Figure 1. Cardiac Mortality at 3 Years in the Cypher and Taxus Groups
The Kaplan-Meier curves show no difference in cardiac mortality at 3 years
between patients treated with a Cypher or a Taxus drug-eluting stent. CI ¼
conﬁdence interval; RR ¼ relative risk.
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31from left main stem ostium to the end of the 5-mm proximal
segments of the left anterior descending coronary artery, left
circumﬂex coronary artery (LCX), as well as of the Ramus
intermedius, if the latter had a vessel size of more than 2 mm
in diameter (10). LMCA stenoses were classiﬁed as ostial
(stenosis located within 3 mm of the LMCA ostium),
midshaft (non-ostial and non-distal stenosis located in the
medial part of the LMCA), and distal (stenosis within 5 mm
of the distal part of the LMCA, and bifurcation/trifurcation
with proximal left anterior descending coronary artery,
proximal LCX, and proximal R. intermedius, if the latter
was >2 mm in diameter). The Medina classiﬁcation
assigned a “1” for the presence of a 50% stenosis of each
branch, as previously published (18). A trifurcation was
present if both the LCX and the R. intermedius were
>2 mm in size with signiﬁcant myocardial territory. The
SYNTAX score was calculated on the basis of the algorithm
developed and presented in the SYNTAX trial using the
calculator on their website, by 2 independent experienced
operators blinded to other patients’ characteristics (3,19,20).
Statistical methods. Baseline descriptive statistics are pre-
sented as frequencies and percentages for categorical vari-
ables, and mean  SD or median (interquartile range) for
continuous variables, depending on the type of distribution
of the variable. The differences between the groups were
assessed using the chi-square test or Fisher exact test for
categorical data, and the Student t test or nonparametric
Wilcoxon test for continuous data. Survival analysis was
made by applying the Kaplan-Meier method. Differences
in survival parameters were assessed for signiﬁcance by
means of the log-rank test. We used Cox proportional
hazards models for the calculation of the risk estimates and
for adjustment for potential confounders that showed sig-
niﬁcant difference in the univariate analysis. A 2-tailed
p value <0.05 was considered to indicate statistical signiﬁ-
cance. Statistical software S-PLUS, version 4.5 (S-PLUS,
Insightful Corporation, Seattle, Washington) was used for
all analyses.
Results
Clinical follow-up at 3 years was available for all patients,
and 530 patients (87%) had re-angiography at 6 to 9
months. Three years after left main DES implantation, the
cardiac mortality rate was 5.8%, and the overall mortality
rate was 12.2%. Comparing the Taxus and Cypher stents at
3 years, there was no signiﬁcant difference regarding
cardiovascular mortality (5.6% in the Taxus group and 5.9%
in the Cypher group, p ¼ 0.97) (Fig. 1) or repeat revascu-
larization (11.6% vs. 13.3%, p ¼ 0.31) (Fig. 2), mostly
repeat PCI. Similarly, there was no difference between
Taxus and Cypher regarding overall mortality (11.7% vs.
12.4%, p ¼ 0.93), MI (6.2% vs. 5.5%, p ¼ 0.69), or stroke
(2.0% vs. 1.4%, p ¼ 0.52). The incidence of deﬁnite stentthrombosis (21) was 0.3% in the Taxus group and 1.0% in
Cypher group, p ¼ 0.32. Given the similar results for the
2 DES platforms at 3 years, we assessed the entire pop-
ulation independent of the DES used and focused our
detailed analysis on speciﬁc anatomic and technical factors
and their impact on outcome.
The complex anatomy of uLMCA lesions was reﬂected
by the majority of treated lesions involving the distal bifur-
cation, present in 384 (63%) patients; 235 (39%) patients
had a true bifurcation lesion (TBL) (Medina 1,1,1)
with 50% stenosis present in all 3 segments of the
bifurcation.
Our ﬁrst analysis focused on the impact of the local
anatomy of the uLMCA and the stenting technique
regarding the long-term outcome. The comparison of
patients with and without TBL regarding baseline and
procedural characteristics, is shown in Tables 1 and 2.
Patients with TBL were older, and had higher Parsonnet
scores and EuroSCOREs (Table 1). They also presented
more often with reduced left ventricular function and
3-vessel disease (Table 2). Given its complexity, the presence
of TBL was associated with a higher need for multiple stents
(72% vs. 37%, p < 0.001) and ﬁnal kissing balloon dilations
(p < 0.001). When viewed separately, the presence of TBL
was a signiﬁcant predictor of ISR (23.4% vs. 14.3%,
p ¼ 0.008) and for TLR (17.8% vs. 9.1%, p < 0.001)
(Fig. 3). Also, the need for multiple stents was a signiﬁcant
predictor of ISR (22.4% vs. 13.1%, p ¼ 0.005) and TLR
(16.2% vs. 8.5%, p ¼ 0.005). Interestingly, even after
correction for TBL, the need for multiple stents remained
a signiﬁcant predictor for ISR (p ¼ 0.04), but not for TLR
(p ¼ 0.09). The predilection site for ISR was the proximal
left coronary circumﬂex artery. Comparing techniques for
multiple stenting, culotte stenting showed better results
compared with T-stenting for ISR (21.3% vs. 55.6%,
Figure 2. Repeat Revascularization Rates at 3 Years Depending on the DES Used
The overall and speciﬁc (PCI or CABG) repeat revascularization rates were similar for the Cypher and Taxus groups. The majority of patients were treated with repeat
percutaneous interventions (PCI). CABG ¼ coronary artery bypass graft; DES ¼ drug-eluting stent; TLR ¼ target lesion revascularization; other abbreviations as in Figure 1.
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32p ¼ 0.02) and for TLR (14.9% vs. 55.6%, p < 0.001). When
comparing left main bifurcations with and without angles
90, there was no difference regarding ISR (16.4% vs.
18.2%, p ¼ 0.63). Final kissing balloon dilation was more
often performed in the presence of TBL, severe calciﬁcation,
and in lesions with pre-dilation of both branches, as well as
after culotte stenting (Table 3). Final kissing balloon dilation
was not associated with signiﬁcant differences in ISR (22.1%Table 1. Baseline Characteristics and Therapy at Discharge
Characteristics
TBL
(n ¼ 235)
No TBL
(n ¼ 372) p Value
Age, yrs 70.4  9.8 68.3  9.6 0.01
Women 51 (22) 88 (24) 0.58
Arterial hypertension 164 (70) 255 (69) 0.75
Hypercholesterolemia 175 (75) 291 (78) 0.29
Diabetes mellitus 69 (29) 107 (29) 0.87
Insulin-requiring 24 (10) 30 (8) 0.37
Current smoker 22 (9) 39 (11) 0.65
Body mass index, kg/m2 26.0 (24.4–28.6) 26.5 (24.2–28.6) 0.80
Acute coronary syndrome 115 (49) 132 (35) 0.001
History of myocardial infarction 68 (29) 93 (25) 0.28
History of PCI 100 (43) 192 (52) 0.03
Creatinine serum level, mg/dl 1.0 (0.8–1.3) 0.9 (0.8–1.1) 0.14
Malignancies 22 (9) 39 (11) 0.65
Parsonnet score 11 (5–21) 9 (4–16) 0.02
EuroSCORE 5 (3–8) 3 (2–6) <0.001
Therapy at hospital discharge*
Statins 223 (95) 356 (96) 0.64
ACE inhibitors 203 (86) 321 (86) 0.97
Angiotensin II type
1 receptor blockers
31 (13) 41 (11) 0.42
Beta-blockers 230 (98) 364 (98) 0.98
Values are mean  SD, n (%), or median (interquartile range). *All patients received aspirin and
clopidogrel at discharge.
ACE ¼ angiotensin-converting enzyme; PCI ¼ percutaneous coronary intervention; TBL ¼
true bifurcation lesion.vs 25.0%, p ¼ 0.73) in patients with multiple stents, nor did
it inﬂuence ISR in patients treated with a single stent (16.7%
vs. 12.8%, p ¼ 0.59) (Fig. 4). Among patients with culotte
stenting, kissing balloon dilation was associated with an ISR
of 21.6% vs. 17.4% for patients without kissing balloon
dilation (p ¼ 0.63) (Fig. 4). Among the few patients with
T-stenting, the rate of ISR was high and not inﬂuenced by ﬁnal
kissing balloon dilation (50.0% vs. 60.0%, p ¼ 0.76) (Fig. 4).
Of the 149 patients (25% of the population) with trifur-
cation morphology, 62 patients had PCIs involving the R.
intermedius. When stratiﬁed by number of stents, patients
with a single stent had similar ISR and TLR rates (p> 0.21),
when comparing patients with and without relevant trifur-
cation. Patients with multiple stents had a trend for higher
ISR and TLR rates (p ¼ 0.06 and p ¼ 0.10, respectively),
when comparing patients with and without trifurcation
morphology. Therefore, a trifurcation morphology was
a predictor for ISR only when multiple stents were needed.
In the second part of our analysis, we assessed the need for
re-intervention of the left main itself, depending on the
overall disease burden, reﬂected by the SYNTAX score; 428
patients (72%) had 3-vessel disease, 87 patients (14%) had
an occluded right coronary artery, and 149 patients (25%)
had a left main trifurcation, reﬂecting the complex coronary
anatomy with a high median SYNTAX score of 27. After
dividing the overall population of 607 patients depending on
the SYNTAX score into the 3 categories according to the
SYNTAX trial (3), the 3 groups were similarly sized in the
overall population: 204 patients (34%) had a SYNTAX score
22, 234 patients (39%) a score 23 to 32, and 169 patients
(28%) had a score 33, with a correlation with age
(p ¼ 0.02) and presence of diabetes mellitus (p ¼ 0.04).
There was a signiﬁcantly lower TLR rate at 3 years in pat-
ients with SYNTAX scores 22 compared with patients
with intermediate scores (23 to 32) and high scores 33,
(9.2% vs. 14.9% vs. 13.0%, p ¼ 0.008) (Fig. 5). Looking at
Table 2. Angiographic and Procedural Characteristics
TBL
(n ¼ 235)
No TBL
(n ¼ 372) p Value
Left ventricular ejection fraction, % 57 (45-62) 59 (49-63) 0.01
Vessel size of left main artery, mm 3.66 (3.36-4.03) 3.83 (3.47-4.18) 0.001
Coronary artery dominance 0.60
Right 181 (77) 299 (80)
Left 32 (14) 42 (11)
Balanced 22 (9) 31 (9)
Three-vessel disease 192 (76) 246 (70) <0.001
Occluded right coronary artery 36 (15) 51 (14) 0.58
Trifurcation morphology 36 (15) 20 (5) <0.001
Stenting technique <0.001
Single stenting 66 (28) 236 (63)
T-stenting 6 (3) 3 (1)
Culotte-stenting 163 (69) 133 (36)
Kissing balloon technique 166 (71) 137 (37) <0.001
Intra-aortic balloon pump 4 (2) 4 (1) 0.51
Abciximab administration 16 (7) 43 (12) 0.05
Bivalirudin administration 33 (14) 63 (17) 0.34
Values are n (%), or median (interquartile range).
TBL ¼ true bifurcation lesion.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 7 , N O . 1 , 2 0 1 4 Tiroch et al.
J A N U A R Y 2 0 1 4 : 2 9 – 3 6 Long-Term Outcome After DES for Left Main Disease
33the entire coronary tree, there was also a correlation between
the SYNTAX score group and the need for any additional
intervention up to 3 years after the primary left main PCI
(15.7% vs. 33.8% vs. 29.0%, p < 0.01). Regarding the
combined endpoint of death, MI, or stroke at 3 years, there
was a better outcome for patients with lower SYNTAX
scores (11.2% vs. 16.7% vs. 24.6% for patients with scores
22, 23 to 32, and 33, respectively, p ¼ 0.006). No
interaction was observed between the SYNTAX score group
and DES type used regarding adverse events.
In the multivariate analysis including relevant variables as
potential confounders (Table 4), the signiﬁcant predictorsFigure 3. Repeat Revascularization Rates Depending on the Presence of a TBL o
(A) shows in-stent restenosis (ISR), and (B) shows target lesion revascularization (TLR)
single or multiple stents.for death, MI, or TLR at 3 years were EuroSCORE,
uLMCA vessel size, and TBL. The signiﬁcant predictors for
TLR up to 3 years were TBL, age, and EuroSCORE.
Discussion
Treatment of complex uLMCA with DES is safe and
effective based on a complete long-term follow-up. The
presence of TBL and need for multiple stents were inde-
pendent predictors for ISR. The overall SYNTAX score was
associated with the TLR rate and with the need for addi-
tional, non-left main interventions at 3 years. The only
anatomic and procedural independent predictor for TLR
was a TBL.
Our analysis has unique strengths: based on a randomized
study in a large cohort of real-world patients with uLMCA
disease and a detailed quantitative coronary angiography eval-
uation, this analysis focuses on anatomic and technical speciﬁ-
cations not readily available in other left main trials. The
complete 3-year follow-up combined with a high re-angiog-
raphy rate of 87% enabled us to correlate the pre- and post-
procedural datawith the re-angiography data and the long-term
outcome, and assess the different variables in the multivariate
analyses.Thehighly experienced operators and the standardized
pre-treatment of all patients, including clopidogrel loadingwith
600 mg followed by treatment for at least 12 months from the
trial initialization in 2005, reduced potential bias through
different operator skills and (21) medical therapies.
Study limitations. The secondary analysis regarding tech-
nical aspects has limitations. The different technical
approaches were not randomized and might reﬂect the
individual operator’s preferences. Still, all operators per-
forming the cases in this study had ample experience over
many years in the 2 afﬁliated study centers, with similar
interventional approaches on the basis of extensive case
discussions during quality assurance conferences.r the Number of Stents Used
rates, depending on the presence of a true bifurcation lesion (TBL) or the use of
Table 3. Angiographic and Procedural Characteristics in Patients With
and Without Kissing Balloon Technique
Final Kissing
(n ¼ 303)
No Final Kissing
(n ¼ 304) p Value
True bifurcation lesion 166 (55) 69 (23) <0.001
Angle <90 86 (28) 84 (28) 0.84
Severe calciﬁcation 196 (65) 221 (73) 0.03
Pre-dilation of both branches 27 (9) 12 (4) 0.01
Stenting technique <0.001
Single stent 28 (9) 274 (90)
T-stenting 4 (1) 5 (2)
Culotte 271 (89) 25 (8)
Values are n (%).
PCI ¼ percutaneous coronary intervention.
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34The 3-year cardiac mortality rate was 5.8% and the TLR
rate was 12.5%, comparable to previous trial results
(3,13,22). The somewhat higher TLR rate compared with
the SYNTAX trial might be related to the high rate of
angiographic follow-up, which always results in a higher rate
of re-intervention. The complex left main anatomy, reﬂected
by the high proportion of distal lesions (63%), including
many trifurcation lesions (25%), and a high SYNTAX score,
required challenging PCI strategies, often using multiple
stents. The analysis of these PCI strategies led to interesting
ﬁndings, directly transferable into everyday practice. Similar
to the ﬁndings from the SYNTAX trial, where the left main
subgroup treated with PCI had a better outcome compared
with the overall PCI population and similar overall MACE
rates as the LM patients treated with CABG, we found that
DES implantation for uLMCA stenosis is safe and efﬁca-
cious out to 3 years (3,13).
If a reasonable result was achieved with provisional DES
implantation for the uLMCA, the long-term results were at
least as good as with multiple stents, even in the presence of
a TBL. These ﬁndings are similar to previous randomized
trials evaluating non-uLMCA bifurcation lesions and
favoring a 1-stent technique (23,24). The ongoing EXCELFigure 4. Interventional Approach and Incidence of ISR
In-stent restenosis (ISR) rates with and without kissing balloon dilation depending o(Evaluation of Xience Prime or Xience V Versus CABG for
Effectiveness of Left Main Revascularization) trial,
comparing treatment of uLMCA with PCI using the Xience
everolimus-eluting stent versus CABG surgery, is strongly
recommending the provisional stenting technique unless the
overstented side branch has a stenosis >70%, corresponding
to our analysis (25). However, the strongest predictor of
restenosis and subsequent TLR is the presence of a TBL.
But even in the presence of a TBL, provisional DES
implantation can result in quite low ISR and TLR rates. In
our analysis, the only independent predictors of hard
endpoints (death and MI) out to 3 years were EuroSCORE
and uLMCA vessel size.
Neither the bifurcation angle nor the use of multiple
stents had an inﬂuence on the long-term outcome if
a reasonable result could be achieved during the interven-
tion. With multiple stents, the culotte technique was mostly
used, followed by T-stenting, thereby ensuring good DES
coverage of the carina. The ﬁnal kissing balloon dilation
effectively reduced slow-ﬂow, and therefore, creatine kinase
and troponin elevations, similar to the CACTUS (Coronary
Bifurcations: Application of the Crushing Technique Using
Sirolimus-Eluting Stents) trial (26). Interestingly, we found
no additional beneﬁt of ﬁnal kissing balloon regarding long-
term outcome and 6-month restenosis rates in the presence
of an unaffected side branch after 1-stent implantation,
questioning the often performed “stent cell” dilation after
provisional stenting. The inhibited neointimal proliferation
with DES covering side branches led to minimal change of
the side-branch stenosis, which was independent of ﬁnal
kissing, suggesting a protective effect by drug diffusion from
the DES to the ostium of the side branch. In addition,
kissing balloon did not affect the long-term angiographic
and clinical outcome after multiple stent implantations in
the presence of a good angiographic result after the last stent
implantation. Similarly, the NORDIC-BALTIC Bifurca-
tion Study III (27) and Brueck et al. (28) also found no
improvement of the immediate or mid-term outcomen number of stents used (A) or stenting technique (B).
Figure 5. Need for Repeat Revascularization Depending on the
SYNTAX Score
Target lesion revascularization (TLR) rates of the left main itself (left) and any
percutaneous coronary intervention (PCI) within the coronary tree (right) at
3 years depending on the SYNTAX score. uLMCA ¼ unprotected left main
coronary artery.
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35compared with sequential dilations for non-uLMCA
bifurcation lesions. On the other hand, by keeping stent
struts open, ﬁnal kissing might allow further access to new
lesions during subsequent interventions.
The overall burden of coronary artery disease, reﬂected
by the SYNTAX score, had a clear correlation with the need
of additional PCI within the coronary tree, but also on the
TLR rate and the clinical endpoint of the left main itself.
This might be explained with the higher prevalence of TBL
and diabetes mellitus in patients with higher SYNTAX
scores, which are predictors of restenosis and clinical events.
The increase of the incidence of hard endpoints with higher
SYNTAX scores supports the current European recom-
mendations regarding a restrictive approach for an inter-
ventional treatment of uLMCA in patients with SYNTAX
scores >32. In concert with the recently published
SYNTAX 3 Years, SYNTAX 5 Years, and Freedom resultsTable 4. Results of the Multivariate Analysis
Variable
Model for MACE at 3 Yrs
Hazard Ratio
(95% CI) p Va
True bifurcation lesion 1.66 (1.11–2.48) 0.0
Age (per 10-yr increase) 0.90 (0.66–1.22) 0.4
Acute coronary syndrome 1.01 (0.67–1.51) 0.9
History of PCI 0.99 (0.68–1.44) 0.9
EuroSCORE (per 1-U increase) 1.69 (1.14–2.51) 0.0
Left ventricular ejection fraction (per 10% reduction) 0.98 (0.78–1.22) 0.8
3-vessel disease 0.98 (0.64–1.51) 0.9
Vessel size of the left main artery (per mm decrease) 1.42 (1.00–2.01) 0.0
Trifurcation lesion 1.04 (0.58–1.87) 0.8
Multiple stents 1.54 (0.82–2.89) 0.1
Final kissing balloon dilation 0.95 (0.51–1.77) 0.8
CI ¼ conﬁdence interval; MACE ¼ major adverse cardiac events (death, myocardial infarction, or targe
TLR ¼ target lesion revascularization.(22,29,30), not the presence of a uLMCA stenosis, but
diabetes mellitus and the SYNTAX score should be
weighted higher regarding the decision for an interventional
or a surgical treatment approach (30).
The DK CRUSH-III (Double-Kissing Crush better than
Culotte Technique for left main bifurcation stenting) trial,
presented recently at the American College of Cardiology
meeting in March 2013, suggested a lower TLR rate with
the crush technique followed by double-kissing balloon
dilation. Still, we do not have enough information regarding
the direct post-procedural results after the compared tech-
niques, especially regarding the steps used in patients
treated with the culotte technique (31). A detailed analysis
similar to ours would help understand the very
large differences in TLR observed in this trial. Obviously,
an optimal interventional result is associated with good
outcomes, as shown by both studies. In our study though,
culotte stenting was performed more often and showed
better results compared with T-stenting, with the crush
technique being performed too rarely to allow reasonable
comparisons.
The EXCEL trial (25) comparing PCI versus CABG in
a speciﬁc population with uLMCA disease is expected to be
completed in 2016. Systematic re-angiography is not
required, so speciﬁc angiographic analyses, comparable to
ours, will be limited. The results of the SYNTAX trial in the
subgroup of patients with isolated left main disease already
encourage cardiologists to pursue an often requested inter-
ventional approach.Conclusions
The good results and the low incidence of stent thrombosis
in this and other studies (32), support the long-term safety
of DES in uLMCA lesions. However, little scientiﬁc dataModel for Death or MI at 3 Yrs Model for TLR at 3 Yrs
lue
Hazard Ratio
(95% CI) p Value
Hazard Ratio
(95% CI) p Value
1 1.23 (0.72–2.07) 0.448 2.12 (1.19–3.77) 0.011
87 1.21 (0.81–1.81) 0.342 0.57 (0.37–0.86) 0.008
62 1.03 (0.61–1.76) 0.909 0.86 (0.48–1.52) 0.593
52 0.87 (0.53–1.44) 0.591 1.06 (0.63–1.80) 0.820
09 1.73 (1.07–2.80) 0.026 2.18 (1.21-3.93) 0.010
60 0.82 (0.63–1.07) 0.138 1.39 (0.97–2.00) 0.075
43 1.28 (0.69–2.34) 0.433 0.89 (0.49–1.59) 0.683
49 1.57 (1.01–2.45) 0.044 1.17 (0.70–1.95) 0.560
90 1.20 (0.56–2.56) 0.632 0.77 (0.33–1.84) 0.564
84 1.13 (0.51–2.52) 0.757 1.64 (0.66–4.10) 0.288
67 1.03 (0.47–2.25) 0.938 1.21 (0.49–2.99) 0.688
t lesion revascularization); MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention;
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36are available to guide the approach for this high-risk inter-
vention. Our analysis may provide guidance for the different
strategies for this challenging intervention.
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